Published in Biotech Business Week, January 24th, 2005
The new credit facility replaces the previous $30,000,000 revolving line of credit agreement with HBCC, which expires in April 2005.
The new facility consists of a $30,000,000 revolving line of credit and a new term loan facility in the amount of $20,000,000. The latter facility may be used to finance certain acquisitions as permitted under the loan agreement between HBCC and VistaCare. Both agreements will expire on December 23, 2009.
VistaCare provides care hrough...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.